GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » EV-to-EBITDA

KAINOS Laboratories (TSE:4556) EV-to-EBITDA : 2.72 (As of May. 25, 2024)


View and export this data going back to 2000. Start your Free Trial

What is KAINOS Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, KAINOS Laboratories's enterprise value is 円2,565 Mil. KAINOS Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円944 Mil. Therefore, KAINOS Laboratories's EV-to-EBITDA for today is 2.72.

The historical rank and industry rank for KAINOS Laboratories's EV-to-EBITDA or its related term are showing as below:

TSE:4556' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.5   Med: 5.46   Max: 9.62
Current: 2.71

During the past 13 years, the highest EV-to-EBITDA of KAINOS Laboratories was 9.62. The lowest was 2.50. And the median was 5.46.

TSE:4556's EV-to-EBITDA is ranked better than
91.39% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.205 vs TSE:4556: 2.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), KAINOS Laboratories's stock price is 円1139.00. KAINOS Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円154.885. Therefore, KAINOS Laboratories's PE Ratio for today is 7.35.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


KAINOS Laboratories EV-to-EBITDA Historical Data

The historical data trend for KAINOS Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KAINOS Laboratories EV-to-EBITDA Chart

KAINOS Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.01 3.87 3.85 2.67 2.28

KAINOS Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 2.28 3.21 2.77 2.46

Competitive Comparison of KAINOS Laboratories's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KAINOS Laboratories's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's EV-to-EBITDA falls into.



KAINOS Laboratories EV-to-EBITDA Calculation

KAINOS Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2565.475/944.179
=2.72

KAINOS Laboratories's current Enterprise Value is 円2,565 Mil.
KAINOS Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円944 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KAINOS Laboratories  (TSE:4556) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

KAINOS Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1139.00/154.885
=7.35

KAINOS Laboratories's share price for today is 円1139.00.
KAINOS Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円154.885.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


KAINOS Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of KAINOS Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


KAINOS Laboratories (TSE:4556) Business Description

Traded in Other Exchanges
N/A
Address
38-18, Hongo 2-chome, Bunkyo-ku,, Tokyo, JPN
KAINOS Laboratories, Inc. is focused on development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sale and export/import of physicochemical measuring equipment for medical use.

KAINOS Laboratories (TSE:4556) Headlines

No Headlines